Your brokerage. Drovix liquidity.
Drovix combines institutional liquidity with its own market-making and bridge technology. See where your platform connects—and where our pricing, execution and risk responsibilities begin.
Integration workspace
Three interfaces.
One counterparty arrangement.
The connection carries prices, instructions and records. Inspect each interface to see which questions belong to the brokerage and which belong to Drovix.
Drovix pricing → Bridge interface → Your platform
Drovix’s own market-making technology sits behind the pricing side of the relationship. The interface connects the agreed instrument universe to the consuming platform.
Do both sides interpret the same instrument and quote in the same way?
Where the bridge ends,
the agreement still matters.
Drovix provides the liquidity relationship and develops the technology behind pricing and connectivity. Instrument permissions, execution handling and commercial terms are agreed for the approved counterparty; a successful connection alone does not establish them.
See the MT5 connectionContinue the review
Integration references
These public references explain the framework. Confirm the terms and technical scope applicable to your arrangement with the desk.
Talk to the institutional desk
Connect your brokerage to the right conversation.
Discuss your platform, instrument scope and integration requirements with the institutional desk.
Contact DrovixLeveraged OTC products, including Forex and CFDs, carry a high level of risk and a counterparty may lose more than its initial margin. The Drovix offering is directed exclusively at Eligible Counterparties and Professional Clients; Drovix does not provide services to retail clients. Content on this page is factual and descriptive only and does not constitute investment advice, a recommendation, or an offer or solicitation to transact.
Drovix acts as principal in bilateral OTC transactions with approved institutional counterparties. It is not a public exchange, MTF, OTF or ECN. Services are not offered to retail clients or in jurisdictions where Drovix is not authorised or permitted to provide them. Instrument access, connectivity, risk parameters and commercial terms are subject to review and the signed institutional services agreement.